Halozyme Therapeutics, Inc. (HALO)

71.21 -0.61 (-0.85%) USD  |  NASDAQ  |  Jan 16, 16:00
71.20 -0.01 (-0.01%) After-Hours: 20:00
More

Halozyme Therapeutics Cash from Discontinued Operations Adjustment (Quarterly)

Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
Johnson & Johnson --
Merck & Co., Inc. --
AIM ImmunoTech, Inc. --
Stryker Corp. --
Skye Bioscience, Inc. --